Delaware |
06-1059331 |
(State or other jurisdiction |
(I.R.S. Employer |
of incorporation or organization) |
Identification No.) |
CIGNA CORPORATION | |||
INDEX |
|||
Page No. | |||
PART I. | |||
| |||
|
|
||
|
|
||
|
|
||
|
|
||
Item
1. Financial Statements |
|||||||
CIGNA
CORPORATION |
|||||||
CONSOLIDATED
STATEMENTS OF INCOME |
|||||||
(In
millions, except per share amounts) |
|||||||
Three
Months Ended |
|||||||
March
31, |
|||||||
2005 |
2004 |
||||||
REVENUES |
|||||||
Premiums
and fees |
$ |
3,362 |
$ |
3,628 |
|||
Net
investment income |
330
|
603
|
|||||
Other
revenues |
636
|
470
|
|||||
Realized
investment gains |
17
|
21
|
|||||
Total
revenues |
4,345
|
4,722
|
|||||
BENEFITS
AND EXPENSES |
|||||||
Health
Care medical claims expense |
1,456
|
1,757
|
|||||
Other
benefit expenses |
868
|
1,207
|
|||||
Other
operating expenses |
1,356
|
1,446
|
|||||
Total
benefits and expenses |
3,680
|
4,410
|
|||||
INCOME
BEFORE INCOME TAXES AND BEFORE |
|||||||
CUMULATIVE
EFFECT OF ACCOUNTING CHANGE |
665
|
312
|
|||||
Income
taxes (benefits): |
|||||||
Current |
59
|
142
|
|||||
Deferred |
170
|
(37 |
) | ||||
Total
taxes |
229
|
105
|
|||||
INCOME
BEFORE CUMULATIVE EFFECT |
|||||||
OF
ACCOUNTING CHANGE |
436
|
207
|
|||||
CUMULATIVE
EFFECT OF ACCOUNTING CHANGE, |
|||||||
NET
OF TAXES |
-
|
(139 |
) | ||||
NET
INCOME |
$ |
436 |
$ |
68 |
|||
EARNINGS
PER SHARE - BASIC |
|||||||
INCOME
BEFORE CUMULATIVE EFFECT |
|||||||
OF
ACCOUNTING CHANGE |
$ |
3.34 |
$ |
1.48 |
|||
CUMULATIVE
EFFECT OF ACCOUNTING CHANGE, |
|||||||
NET
OF TAXES |
-
|
(0.99 |
) | ||||
NET
INCOME |
$ |
3.34 |
$ |
0.49 |
|||
EARNINGS
PER SHARE - DILUTED |
|||||||
INCOME
BEFORE CUMULATIVE EFFECT |
|||||||
OF
ACCOUNTING CHANGE |
$ |
3.28 |
$ |
1.47 |
|||
CUMULATIVE
EFFECT OF ACCOUNTING CHANGE, |
|||||||
NET
OF TAXES |
-
|
(0.99 |
) | ||||
NET
INCOME |
$ |
3.28 |
$ |
0.48 |
|||
DIVIDENDS
DECLARED PER SHARE |
$ |
0.03 |
$ |
0.33 |
|||
The
accompanying Notes to the Financial Statements are an integral part of
these statements. |
|||||||
CONSOLIDATED
BALANCE SHEETS |
|||||||||||||
(In
millions, except per share amounts) |
|||||||||||||
As
of |
|
As
of |
|||||||||||
|
|
|
March
31, |
|
December
31, |
||||||||
|
|
|
|
2005 |
2004 |
||||||||
ASSETS |
|||||||||||||
Investments: |
|||||||||||||
Fixed maturities, at fair value (amortized cost, $14,969;
$14,812) |
$ |
16,060 |
$ |
16,136 |
|||||||||
Equity securities, at fair value (cost, $13; $11) |
32
|
33
|
|||||||||||
Mortgage loans |
3,355
|
3,529
|
|||||||||||
Policy loans |
1,601
|
1,594
|
|||||||||||
Real estate |
77
|
78
|
|||||||||||
Other long-term investments |
482
|
478
|
|||||||||||
Short-term investments |
61
|
71
|
|||||||||||
Total
investments |
21,668
|
21,919
|
|||||||||||
Cash
and cash equivalents |
2,400
|
2,519
|
|||||||||||
Accrued
investment income |
297
|
285
|
|||||||||||
Premiums,
accounts and notes receivable |
1,663
|
1,628
|
|||||||||||
Reinsurance
recoverables |
9,749
|
14,595
|
|||||||||||
Deferred
policy acquisition costs |
563
|
544
|
|||||||||||
Property
and equipment |
747
|
777
|
|||||||||||
Deferred
income taxes |
1,260
|
1,383
|
|||||||||||
Goodwill |
1,620
|
1,620
|
|||||||||||
Other
assets, including other intangibles |
303
|
312
|
|||||||||||
Separate
account assets |
10,607
|
35,477
|
|||||||||||
Total
assets |
$ |
50,877 |
$ |
81,059 |
|||||||||
LIABILITIES |
|||||||||||||
Contractholder
deposit funds |
$ |
12,966 |
$ |
17,839 |
|||||||||
Future
policy benefits |
8,463
|
8,428
|
|||||||||||
Unpaid
claims and claim expenses |
4,319
|
4,311
|
|||||||||||
Health
Care medical claims payable |
1,337
|
1,594
|
|||||||||||
Unearned
premiums |
345
|
343
|
|||||||||||
Total
insurance and contractholder liabilities |
27,430
|
32,515
|
|||||||||||
Accounts
payable, accrued expenses and other liabilities |
6,027
|
6,359
|
|||||||||||
Short-term
debt |
100
|
-
|
|||||||||||
Long-term
debt |
1,338
|
1,438
|
|||||||||||
Nonrecourse
obligations |
66
|
67
|
|||||||||||
Separate
account liabilities |
10,607
|
35,477
|
|||||||||||
Total
liabilities |
45,568
|
75,856
|
|||||||||||
CONTINGENCIES
- NOTE 12 |
|||||||||||||
SHAREHOLDERS'
EQUITY |
|||||||||||||
Common
stock (par value per share, $0.25; shares issued,
160; 160) |
40
|
40
|
|||||||||||
Additional
paid-in capital |
2,297
|
2,360
|
|||||||||||
Net
unrealized appreciation, fixed maturities |
$ |
247 |
$ |
393 |
|||||||||
Net
unrealized appreciation, equity securities |
12
|
14
|
|||||||||||
Net
unrealized depreciation, derivatives |
(18 |
) |
(16 |
) |
|||||||||
Net
translation of foreign currencies |
5
|
2
|
|||||||||||
Minimum
pension liability adjustment |
(729 |
) |
(729 |
) |
|||||||||
Accumulated
other comprehensive loss |
(483 |
) |
(336 |
) | |||||||||
Retained
earnings |
4,112
|
3,679
|
|||||||||||
Less
treasury stock, at cost |
(657 |
) |
(540 |
) | |||||||||
Total
shareholders' equity |
5,309
|
5,203
|
|||||||||||
Total
liabilities and shareholders' equity |
$ |
50,877 |
$ |
81,059 |
|||||||||
SHAREHOLDERS'
EQUITY PER SHARE |
$ |
40.56 |
$ |
39.41 |
|||||||||
The
accompanying Notes to the Financial Statements are an integral part of
these statements. |
|||||||||||||
CONSOLIDATED
STATEMENTS OF COMPREHENSIVE INCOME AND CHANGES IN SHAREHOLDERS'
EQUITY |
Three
Months Ended March 31, |
2005
|
2004
|
|||||||||||
Common
stock |
$ |
40 |
$ |
69 |
|||||||||
Additional
paid-in capital, January 1 |
2,360
|
3,647
|
|||||||||||
Issuance
of stock for employee benefits plans |
(63 |
) |
57 |
||||||||||
Additional
paid-in capital, March 31 |
2,297
|
3,704
|
|||||||||||
Accumulated
other comprehensive loss, January 1 |
(336 |
) |
(54 |
) | |||||||||
Net
unrealized appreciation (depreciation), fixed maturities |
$ |
(146 |
) |
(146 |
) |
$ |
153 |
153
|
|||||
Net
unrealized depreciation, equity securities |
(2 |
) |
(2 |
) |
(1 |
) |
(1 |
) | |||||
Net
unrealized appreciation (depreciation) on securities |
(148 |
) |
152
|
||||||||||
Net
unrealized appreciation (depreciation), derivatives |
(2 |
) |
(2 |
) |
7
|
7
|
|||||||
Net
translation of foreign currencies |
3
|
3
|
9
|
9
|
|||||||||
Minimum
pension liability adjustment |
-
|
-
|
(113 |
) |
(113 |
) | |||||||
Other
comprehensive income (loss) |
(147 |
) |
55
|
||||||||||
Accumulated
other comprehensive income (loss), March
31 |
(483 |
) |
1
|
||||||||||
Retained
earnings, January 1 |
3,679
|
9,502
|
|||||||||||
Net
income |
436
|
436
|
68
|
68
|
|||||||||
Common
dividends declared |
(3 |
) |
(47 |
) | |||||||||
Retained
earnings, March 31 |
4,112
|
9,523
|
|||||||||||
Treasury
stock, January 1 |
(540 |
) |
(8,557 |
) | |||||||||
Repurchase
of common stock |
(240 |
) |
-
|
||||||||||
Other,
primarily issuance of treasury stock for employee
benefit plans |
123
|
(20 |
) | ||||||||||
Treasury
stock, March 31 |
(657 |
) |
(8,577 |
) | |||||||||
TOTAL
COMPREHENSIVE INCOME AND SHAREHOLDERS' EQUITY |
$ |
289 |
$ |
5,309 |
$ |
123 |
$ |
4,720 |
The
accompanying Notes to the Financial Statements are an integral part of
these statements. |
CONSOLIDATED
STATEMENTS OF CASH FLOWS |
|||||||
(In millions) |
|||||||
Three
Months Ended March 31, |
|||||||
|
2005 |
2004 |
|||||
CASH
FLOWS FROM OPERATING ACTIVITIES |
|||||||
Income
before cumulative effect of accounting change |
$ |
436 |
$ |
207 |
|||
Adjustments
to reconcile income before cumulative effect of |
|||||||
accounting change to net cash provided by operating
activities: |
|||||||
Insurance
liabilities |
(216 |
) |
(380 |
) | |||
Reinsurance
recoverables |
(52 |
) |
95
|
||||
Deferred
policy acquisition costs |
(17 |
) |
(27 |
) | |||
Premiums,
accounts and notes receivable |
146
|
294
|
|||||
Accounts
payable, accrued expenses and other liabilities |
113
|
(28 |
) | ||||
Current
income taxes |
(42 |
) |
174
|
||||
Deferred
income taxes |
170
|
(37 |
) | ||||
Realized
investment (gains) |
(17 |
) |
(21 |
) | |||
Depreciation
and amortization |
62
|
62
|
|||||
Gains
on sales of businesses |
(286 |
) |
(14 |
) | |||
Proceeds
from sales and maturities of securities supporting |
|||||||
experience-rated pension policyholder contracts, net of
purchases |
-
|
782
|
|||||
Other,
net |
(26 |
) |
16
|
||||
Net
cash provided by operating activities |
271
|
1,123
|
|||||
CASH
FLOWS FROM INVESTING ACTIVITIES |
|||||||
Proceeds
from investments sold: |
|||||||
Fixed
maturities |
594
|
650
|
|||||
Equity
securities |
4
|
3
|
|||||
Mortgage
loans |
151
|
64
|
|||||
Other
(primarily short-term investments) |
2,571
|
1,338
|
|||||
Investment
maturities and repayments: |
|||||||
Fixed
maturities |
194
|
187
|
|||||
Mortgage
loans |
76
|
361
|
|||||
Investments
purchased: |
|||||||
Fixed
maturities |
(904 |
) |
(1,482 |
) | |||
Equity
securities |
(5 |
) |
(6 |
) | |||
Mortgage
loans |
(53 |
) |
(331 |
) | |||
Other
(primarily short-term investments) |
(2,659 |
) |
(1,277 |
) | |||
Property
and equipment, net |
(23 |
) |
(18 |
) | |||
Other,
net |
-
|
(4 |
) | ||||
Net
cash used in investing activities |
(54 |
) |
(515 |
) | |||
CASH
FLOWS FROM FINANCING ACTIVITIES |
|||||||
Deposits
and interest credited to contractholder deposit funds |
176
|
1,677
|
|||||
Withdrawals
and benefit payments from contractholder deposit funds |
(168 |
) |
(2,108 |
) | |||
Change
in cash overdraft position |
(193 |
) |
(50 |
) | |||
Repurchase
common stock |
(242 |
) |
-
|
||||
Issuance
of common stock |
94
|
19
|
|||||
Common
dividends paid |
(3 |
) |
(47 |
) | |||
Net
cash used in financing activities |
(336 |
) |
(509 |
) | |||
Net
increase (decrease) in cash and cash equivalents |
(119 |
) |
99
|
||||
Cash
and cash equivalents, beginning of period |
2,519
|
1,392
|
|||||
Cash
and cash equivalents, end of period |
$ |
2,400 |
$ |
1,491 |
|||
Supplemental
Disclosure of Cash Information: |
|||||||
Income
taxes paid (received), net |
$ |
91 |
$ |
(32 |
) | ||
Interest
paid |
$ |
22 |
$ |
24 |
|||
The
accompanying Notes to the Financial Statements are an integral part of
these statements. |
|||||||
|
|||||||
|
|||||||
Three
Months
Ended |
|||||||
(In
millions, except per share amounts) |
March
31, 2004 |
||||||
Net
income, prior to implementation |
$ |
73 |
|||||
Compensation
expense for stock options, net of taxes, prior to
implementation |
5 |
||||||
Compensation
expense for stock options, net of taxes, under SFAS 123R |
(10 |
) | |||||
Net
income under SFAS 123R |
$ |
68 |
|||||
Net
income per share: |
|||||||
Basic
- prior to implementation |
$ |
0.52 |
|||||
Basic
- as restated |
$ |
0.49 |
|||||
Diluted
- prior to implementation |
$ |
0.52 |
|||||
Diluted
- as restated |
$ |
0.48 |
Three
Months
Ended
March
31, |
|||||||
(In
millions) |
2005 |
|
2004 |
||||
Compensation
cost |
$ |
6 |
$ |
21 |
|||
Tax
benefits |
$ |
2 |
$ |
7 |
Three
Months
Ended
March
31, |
|||||||
(Options
in thousands) |
2005 |
|
2004 |
||||
Dividend
yield |
0.1 |
% |
0.2 |
% | |||
Expected
volatility |
35.0 |
% |
47.6 |
% | |||
Risk-free
interest rate |
3.9 |
% |
2.2 |
% | |||
Expected
option life |
5.25
years |
3.3
years |
|||||
Options
granted |
781 |
3,047 |
|||||
Weighted
average fair value of options granted |
$ |
33.88 |
$ |
19.66 |
Three
Months
Ended
March
31, |
|||||||
(Grants
in thousands) |
2005 |
|
2004 |
||||
Restricted
stock granted |
282 |
417 |
|||||
Weighted
average fair value |
$ |
91.36 |
$ |
56.92 |
(In
millions) |
Health
Care |
|
Corporate |
|
Total |
|||||
First
quarter 2005 charge |
$ |
22 |
$ |
29 |
$ |
51 |
||||
First
quarter 2005 payments |
(1 |
) |
(2 |
) |
(3 |
) | ||||
Balance
as of March 31, 2005 |
$ |
21 |
$ |
27 |
$ |
48 |
(In
millions) |
Health
Care/ Disability and Life* |
|
Corporate |
|
Total |
|||||
Balance
as of December 31, 2004: |
||||||||||
Severance |
$ |
11 |
$ |
9 |
$ |
20 |
||||
Real
estate |
8 |
1 |
9 |
|||||||
First
quarter 2005 payments: |
||||||||||
Severance |
(6 |
) |
(6 |
) |
(12 |
) | ||||
Real
estate |
(1 |
) |
- |
(1 |
) | |||||
Balance
as of March 31, 2005 |
$ |
12 |
$ |
4 |
$ |
16 |
· |
The
reserves represent estimates of the present value of net amounts expected
to be paid, less the present value of net future premiums. Included in net
amounts expected to be paid is the excess of the guaranteed death benefits
over the values of the contractholders’ accounts (based on underlying
equity and bond mutual fund investments). |
· |
The
reserves include an estimate for partial surrenders that essentially lock
in the death benefit for a particular policy based on annual election
rates that vary from 0-15% depending on the net amount at risk for each
policy. |
· |
The
mean investment performance assumption is 5% considering CIGNA's program
to reduce equity market exposures using futures and forward
contracts. |
· |
The
volatility assumption is 15-30%, varying by equity fund type; 3-8%,
varying by bond fund type; and 1% for money market
funds. |
· |
The
mortality assumption is 70-75% of the 1994 Group Annuity Mortality table,
with 1% annual improvement beginning January 1,
2000. |
· |
The
lapse rate assumption is 0-15%, depending on contract type, policy
duration and the ratio of the net amount at risk to account
value. |
Three
Months
Ended
March
31, |
|||||||
(In
millions) |
2005 |
|
2004 |
||||
Service
cost |
$ |
17 |
$ |
22 |
|||
Interest
cost |
55 |
55 |
|||||
Expected
return on plan
assets |
(46 |
) |
(48 |
) | |||
Amortization
of:
Net
loss from past
experience |
36 |
18 |
|||||
Prior
service cost |
(1 |
) |
— |
||||
Net
pension cost |
$ |
61 |
$ |
47 |
Three
Months
Ended
March
31, |
|||||||
(In
millions) |
2005 |
|
|
2004 |
|||
Service
cost |
$ |
1 |
$ |
1 |
|||
Interest
cost |
9 |
9 |
|||||
Expected
return on plan
assets |
(1 |
) |
(1 |
) | |||
Amortization
of prior
service
cost |
(5 |
) |
(4 |
) | |||
Net
other postretirement
benefit
cost |
$ |
4 |
$ |
5 |
Three
Months
Ended
March
31, |
|||||||
(In
millions) |
|
2005 |
|
2004 |
|||
Fixed
maturities |
$ |
13 |
$ |
9 |
|||
Equity
securities |
1 |
2 |
|||||
Real
estate |
— |
(2 |
) | ||||
Derivatives
and other |
3 |
12 |
|||||
Realized
investment gains,
before
income taxes |
17 |
21 |
|||||
Less
income taxes |
6 |
7 |
|||||
Net
realized investment gains |
$ |
11 |
$ |
14 |
Three
Months
Ended
March
31, |
|||||||
(In
millions) |
2005 |
|
2004 |
||||
Proceeds
from sales |
$ |
598 |
$ |
653 |
|||
Gross
gains on sales |
$ |
15 |
$ |
34 |
|||
Gross
losses on sales |
$ |
(6 |
) |
$ |
(3 |
) |
· |
length
of time and severity of decline; |
· |
financial
health and specific near term prospects of the issuer; and
|
· |
changes
in the regulatory, economic or general market environment of the issuer’s
industry or geographic region. |
(In millions) |
Fair
Value |
Amortized
Cost |
Unrealized
Depreciation |
|||||||
One
year or less: |
||||||||||
Investment
grade |
$ |
3,596 |
$ |
3,667 |
$ |
(71 |
) | |||
Below
investment grade |
$ |
189 |
$ |
195 |
$ |
(6 |
) | |||
More
than one year: |
||||||||||
Investment
grade |
$ |
516 |
$ |
537 |
$ |
(21 |
) |
· |
amounts
required to adjust future policy benefits for certain annuities;
and |
· |
amounts
required to adjust other liabilities after the initial reclassification of
unrealized appreciation under a modified coinsurance
arrangement. |
(In
millions) |
Pre-Tax |
|
Tax
(Expense) Benefit |
|
After-Tax
|
|||||
Three
Months Ended March 31, |
||||||||||
2005 |
||||||||||
Net
unrealized depreciation, securities: |
||||||||||
Unrealized
depreciation on securities held |
$ |
(213 |
) |
$ |
74 |
$ |
(139 |
) | ||
Gains
realized on securities |
(14 |
) |
5 |
(9 |
) | |||||
Net
unrealized depreciation, securities |
$ |
(227 |
) |
$ |
79 |
$ |
(148 |
) | ||
Net
unrealized depreciation, derivatives |
$ |
(2 |
) |
$ |
— |
$ |
(2 |
) | ||
Net
translation of foreign currencies |
$ |
5 |
$ |
(2 |
) |
$ |
3 |
|||
2004 |
||||||||||
Net
unrealized appreciation,
securities: |
||||||||||
Unrealized
appreciation on securities held |
$ |
244 |
$ |
(85 |
) |
$ |
159 |
|||
Gains
realized on securities |
(11 |
) |
4 |
(7 |
) | |||||
Net
unrealized appreciation, securities |
$ |
233 |
$ |
(81 |
) |
$ |
152 |
|||
Net
unrealized appreciation, derivatives |
$ |
11 |
$ |
(4 |
) |
$ |
7 |
|||
Net
translation of foreign currencies |
$ |
13 |
$ |
(4 |
) |
$ |
9 |
|||
Minimum
pension liability adjustment |
$ |
(174 |
) |
$ |
61 |
$ |
(113 |
) |
(Dollars
in millions, except per share amounts) |
Basic |
|
Effect
of Dilution |
|
Diluted |
||||||||||||||
Three
Months Ended March 31, |
|||||||||||||||||||
2005 |
|||||||||||||||||||
Income
before cumulative effect of accounting change |
$ |
436 |
— |
$ |
436 |
||||||||||||||
Shares
(in
thousands): |
|||||||||||||||||||
Weighted
average |
130,722 |
— |
130,722 |
||||||||||||||||
Options
and restricted stock grants |
2,004 |
2,004 |
|||||||||||||||||
Total
shares |
130,722 |
2,004 |
132,726 |
||||||||||||||||
EPS |
$ |
3.34 |
$ |
(0.06 |
) |
$ |
3.28 |
||||||||||||
2004 |
|||||||||||||||||||
Income
before cumulative effect of accounting change |
$ |
207 |
$ |
207 |
|||||||||||||||
Shares
(in
thousands): |
|||||||||||||||||||
Weighted
average |
139,999 |
— |
139,999 |
||||||||||||||||
Options
and restricted stock grants |
1,116 |
1,116 |
|||||||||||||||||
Total
shares |
139,999 |
1,116 |
141,115 |
||||||||||||||||
EPS |
$ |
1.48 |
(0.01 |
) |
$ |
1.47 |
Three
Months Ended
March
31, |
|||||||
(In
millions) |
2005 |
|
2004 |
||||
Premiums
and fees |
|||||||
Individual
life insurance and
annuity
business sold |
$ |
67 |
$ |
73 |
|||
Other |
41 |
39 |
|||||
Total |
$ |
108 |
$ |
112 |
|||
Reinsurance
recoveries |
|||||||
Individual
life insurance and
annuity
business sold |
$ |
63 |
$ |
79 |
|||
Other |
43 |
38 |
|||||
Total |
$ |
106 |
$ |
117 |
Three
Months
Ended
March
31, |
|||||||
(In
millions) |
2005 |
|
2004 |
||||
Premiums
and fees and other revenues |
|||||||
Health
Care |
$ |
2,758 |
$ |
3,043 |
|||
Disability
and Life |
557 |
527 |
|||||
International
|
300 |
241 |
|||||
Run-off
Retirement |
274 |
234 |
|||||
Run-off
Reinsurance |
61 |
(9 |
) | ||||
Other
Operations |
57 |
81 |
|||||
Corporate |
(9 |
) |
(19 |
) | |||
Total |
$ |
3,998 |
$ |
4,098 |
|||
Income
(loss) before cumulative effect of
accounting
change |
|||||||
Health
Care |
$ |
191 |
$ |
152 |
|||
Disability
and Life |
59 |
39 |
|||||
International
|
30 |
15 |
|||||
Run-off
Retirement |
166 |
27 |
|||||
Run-off
Reinsurance |
(16 |
) |
(10 |
) | |||
Other
Operations |
30 |
18 |
|||||
Corporate
|
(35 |
) |
(48 |
) | |||
Segment
earnings |
425 |
193 |
|||||
Realized
investment gains, net of taxes |
11 |
14 |
|||||
Income
before cumulative effect of accounting
change |
$ |
436 |
$ |
207 |
· |
These
liabilities represent estimates of the present value of net amounts
expected to be paid, less the present value of net future premiums
expected to be received. Included in net amounts expected to be paid is
the excess of the expected value of the income benefits over the values of
the annuitant’s accounts at the time of annuitization. The assets
associated with these contracts represent receivables in connection with
reinsurance that CIGNA has purchased from third parties.
|
· |
The
market return assumption is 9-12% varying by equity fund type; 6-9%
varying by bond fund type; and 5-6% for money market funds.
|
· |
The
volatility assumption is 14-24%, varying by equity fund type; 6-7%,
varying by bond fund type; and 2-3% for money market
funds. |
· |
The
discount rate is 5.75%. |
· |
The
projected interest rate used to calculate the reinsured income benefits at
the time of annuitization varies by economic scenario, reflects interest
rates as of the valuation date, and has a long-term mean rate of 5-6% and
a standard deviation of 12-13%. |
· |
The
mortality assumption is 75% of the 1994 Group Annuity Mortality table,
with 1% annual improvement beginning January 1,
2000. |
· |
The
lapse rate assumption is 2-15%, depending on policy
duration. |
· |
The
annuity election rate assumption is that no more than 5% of the policies
eligible to annuitize their variable annuity contracts will do so each
year. |
· |
No
annuitants surrendered their accounts, and |
· |
All
annuitants lived to elect their benefits;
and |
· |
All
annuitants elected to receive their benefit on the first available date (
2005 through 2014); and |
· |
All
underlying mutual fund investment values remained at the March 31, 2005
value of $3.2 billion, with no future
returns. |
· |
additional
mandated benefits or services that increase costs without improving the
quality of care; |
· |
legislation
that would grant plan participants broader rights to sue their health
plans; |
· |
changes
in ERISA regulations resulting in increased administrative burdens and
costs; |
· |
additional
restrictions on the use of prescription drug formularies;
|
· |
additional
privacy legislation and regulations that interfere with the proper use of
medical information for research, coordination of medical care and disease
and disability management; |
· |
additional
rules establishing the time periods for payment of health care provider
claims that vary from state to state; and |
· |
legislation
that would exempt independent physicians from antitrust
laws. |
INDEX |
|
· |
cost
trends and inflation levels for medical and related
services; |
· |
patterns
of utilization of medical and other
services; |
· |
employment
levels; |
· |
the
tort liability system; |
· |
interest
rates and equity market returns; |
· |
regulations
and tax rules related to the provision and administration of employee
benefit plans; and |
· |
initiatives
to increase health care regulation. |
· |
competitiveness
of CIGNA's product design and service
quality; |
· |
the
absolute level of and trends in benefit
costs; |
· |
the
volume of customers served and the mix of products and services purchased
by those customers; |
· |
the
ability to price products and services competitively at levels that
appropriately account for underlying cost inflation and utilization
patterns; and |
· |
the
relationship between administrative costs and
revenue. |
|
|||||||
FINANCIAL
SUMMARY
|
Three
Months
Ended
March
31, | ||||||
(In
millions) |
2005 |
|
2004 |
||||
Premiums
and fees |
$ |
3,362 |
$ |
3,628 |
|||
Net
investment income |
330 |
603 |
|||||
Other
revenues |
636 |
470 |
|||||
Realized
investment gains |
17 |
21 |
|||||
Total
revenues |
4,345 |
4,722 |
|||||
Benefits
and expenses |
3,680 |
4,410 |
|||||
Income
before taxes |
665 |
312 |
|||||
Income
taxes |
229 |
105 |
|||||
Income
before cumulative effect of accounting change |
436 |
207 |
|||||
Cumulative
effect of accounting change, net of taxes (See Note 2 to the Financial
Statements) |
— |
(139 |
) | ||||
Net
income |
$ |
436 |
$ |
68 |
|||
Realized
investment gains,
net
of taxes |
$ |
11 |
$ |
14 |
SPECIAL
ITEMS |
|||||||
(In millions) |
|||||||
Pre-Tax
Benefit (Charge) |
After-Tax
Benefit (Charge) |
||||||
Three
Months Ended March 31, |
|||||||
2005 |
|||||||
Accelerated
recognition of deferred gain on sale of retirement benefits business (see
page 21) |
$ |
260 |
$ |
169 |
|||
Cost
reduction charge (see page 22) |
(51 |
) |
(33 |
) | |||
Charge
associated with a modified coinsurance arrangement (see page
22) |
(12 |
) |
(8 |
) | |||
Total |
$ |
197 |
$ |
128 |
|||
2004 |
|||||||
Cost
reduction charge |
$ |
(75 |
) |
$ |
(49 |
) | |
Effect
of new accounting pronouncement (See Note 2 to the Financial
Statements) |
(17 |
) |
(11 |
) | |||
Total |
$ |
(92 |
) |
$ |
(60 |
) |
· |
lower
premiums and fees in the Health Care segment primarily due to lower
membership; and |
· |
reduced
net investment income primarily related to the sale of the retirement
benefits business. |
· |
recognition
of deferred gain amortization associated with the sale of the retirement
benefits business; and |
· |
gains
for the three months of 2005 from futures and forward contracts, compared
with losses in the prior year, in connection with the program to reduce
equity market risks (see guaranteed minimum death benefit
contracts on page 29). |
· |
it
requires assumptions to be made that were uncertain at the time the
estimate was made; and |
· |
changes
in the estimate or different estimates that could have been selected could
have a material impact on CIGNA’s consolidated results of operations or
financial condition. |
· |
future
policy benefits - guaranteed minimum death benefits;
|
· |
Health
Care medical claims payable; |
· |
other
liabilities and other assets - guaranteed minimum income benefits;
|
· |
reinsurance
recoverables for Run-off Reinsurance; and |
· |
investments
- recognition of losses from other- than-temporary impairments of public
and private placement fixed maturities. |
(In
millions) |
Health
Care |
|
Corporate |
|
Total |
|||||
First
quarter 2005 charge |
$ |
22 |
$ |
29 |
$ |
51 |
||||
First
quarter 2005 payments |
(1 |
) |
(2 |
) |
(3 |
) | ||||
Balance
as of March 31, 2005 |
$ |
21 |
$ |
27 |
$ |
48 |
(In
millions) |
Health
Care/ Disability and Life* |
|
Corporate |
|
Total |
|||||
Balance
as of December 31, 2004: |
||||||||||
Severance |
$ |
11 |
$ |
9 |
$ |
20 |
||||
Real
estate |
8 |
1 |
9 |
|||||||
First
quarter 2005 payments: |
||||||||||
Severance |
(6 |
) |
(6 |
) |
(12 |
) | ||||
Real
estate |
(1 |
) |
- |
(1 |
) | |||||
Balance
as of March 31, 2005 |
$ |
12 |
$ |
4 |
$ |
16 |
· |
additional
mandated benefits or services that increase costs without improving the
quality of care; |
· |
legislation
that would grant plan participants broader rights to sue their health
plans; |
· |
changes
in ERISA regulations resulting in increased administrative burdens and
costs; |
· |
additional
restrictions on the use of prescription drug formularies;
|
· |
additional
privacy legislation and regulations that interfere with the proper use of
medical information for research, coordination of medical care and disease
and disability management; |
· |
additional
rules establishing the time periods for payment of health care provider
claims that vary from state to state; and |
· |
legislation
that would exempt independent physicians from antitrust
laws. |
FINANCIAL
SUMMARY |
Three
Months
Ended
March
31, |
||||||
(In
millions) |
2005 |
|
2004 |
||||
Premiums
and fees |
$ |
2,499 |
$ |
2,790 |
|||
Net
investment income |
68 |
72 |
|||||
Other
revenues |
259 |
253 |
|||||
Segment
revenues |
2,826 |
3,115 |
|||||
Benefits
and expenses |
2,534 |
2,879 |
|||||
Income
before taxes |
292 |
236 |
|||||
Income
taxes |
101 |
84 |
|||||
Segment
earnings |
$ |
191 |
$ |
152 |
|||
Realized
investment
gains,
net of taxes |
$ |
2 |
$ |
4 |
|||
Special
item (after-tax) included in
segment
earnings: |
|||||||
Cost
reduction charge |
$ |
(14 |
) |
$ |
(28 |
) |
Three
Months
Ended
March
31, |
|||||||
(In millions) |
2005 |
|
2004 |
||||
Commercial
HMO |
$ |
656 |
$ |
844 |
|||
Experience-rated
medical |
650 |
736 |
|||||
Dental |
226 |
221 |
|||||
Medicare
and Medicaid |
70 |
75 |
|||||
Other
medical |
343 |
283 |
|||||
Life
and other non-medical |
108 |
136 |
|||||
Total
premiums |
2,053 |
2,295 |
|||||
Fees |
446 |
495 |
|||||
Total
premiums and fees |
$ |
2,499 |
$ |
2,790 |
Three
Months
Ended
March
31, |
|||||||
(In millions) |
2005 |
|
2004 |
||||
Medical
claims expense |
$ |
1,456 |
$ |
1,757 |
|||
Other
benefit expenses |
97 |
132 |
|||||
Other
operating expenses |
981 |
990 |
|||||
Total
benefits and expenses |
$ |
2,534 |
$ |
2,879 |
(In thousands) |
|
2005 |
|
2004 |
|||
Guaranteed
cost: |
|||||||
Commercial
HMO |
794 |
1,069 |
|||||
Medicare
and Medicaid |
33 |
38 |
|||||
Other |
160 |
65 |
|||||
Experience-rated1 |
1,194 |
1,304 |
|||||
Service
|
6,825 |
7,740 |
|||||
Total
medical membership |
9,006 |
10,216 |
· |
offering
products that meet emerging market and consumer
trends; |
· |
improving
medical membership results; |
· |
lowering
medical cost trends; |
· |
continuing
to deliver quality member service; and |
· |
lowering
administrative expenses. |
· |
a
diverse product portfolio that meets emerging consumer-directed
trends; |
· |
consistent
and responsive member service delivery; |
· |
competitive
provider networks; and |
· |
strong
clinical quality in medical, specialty health care and disability
management; |
FINANCIAL
SUMMARY |
Three
Months
Ended
March
31, |
||||||
(In
millions) |
2005 |
|
2004 |
||||
Premiums
and fees |
$ |
508 |
$ |
475 |
|||
Net
investment income |
66 |
60 |
|||||
Other
revenues |
49 |
52 |
|||||
Segment
revenues |
623 |
587 |
|||||
Benefits
and expenses |
540 |
533 |
|||||
Income
before taxes |
83 |
54 |
|||||
Income
taxes |
24 |
15 |
|||||
Segment
earnings |
$ |
59 |
$ |
39 |
|||
Realized
investment gains,
net
of taxes |
$ |
1 |
$ |
1 |
|||
Special
item (after-tax)
included
in segment
earnings: |
|||||||
Cost
reduction charge |
$ |
— |
$ |
(1 |
) |
· |
disability
insurance; |
· |
disability
and workers’ compensation case management; |
· |
life
insurance; and |
· |
accident
and specialty association insurance. |
· |
strong
disability management execution and favorable emerging claim experience;
and |
· |
favorable
mortality experience and improved expense management in the life insurance
business. |
FINANCIAL
SUMMARY
|
Three
Months
Ended
March
31, |
||||||
(In
millions) |
2005 |
|
2004 |
||||
Premiums
and fees |
$ |
302 |
$ |
239 |
|||
Net
investment income |
14 |
12 |
|||||
Other
revenues |
(2 |
) |
2 |
||||
Segment
revenues |
314 |
253 |
|||||
Benefits
and expenses |
268 |
230 |
|||||
Income
before taxes |
46 |
23 |
|||||
Income
taxes |
16 |
8 |
|||||
Segment
earnings |
$ |
30 |
$ |
15 |
|||
Realized
investment gains,
net
of taxes |
$ |
— |
$ |
1 |
· |
sales
growth and improved customer retention in the life, accident and health
insurance operations, particularly in South Korea;
and |
· |
higher
premiums and fees for the expatriate employee benefits business
particularly resulting from membership
growth. |
FINANCIAL
SUMMARY
|
Three
Months
Ended
March
31, |
||||||||||||
(In
millions) |
2005 |
|
2004 |
||||||||||
Premiums
and fees |
$ |
— |
$ |
69 |
|||||||||
Net
investment income |
38 |
316 |
|||||||||||
Other
revenues |
274 |
165 |
|||||||||||
Segment
revenues |
312 |
550 |
|||||||||||
Benefits
and expenses |
52 |
516 |
|||||||||||
Income
before taxes |
260 |
34 |
|||||||||||
Income
taxes |
94 |
7 |
|||||||||||
Segment
earnings |
$ |
166 |
$ |
27 |
|||||||||
Realized
investment gains,
net
of taxes |
$ |
8 |
$ |
5 |
|||||||||
Special
items (after-tax) included in segment
earnings: |
|||||||||||||
Accelerated
recognition of deferred
gain on sale of retirement
benefits business |
$ |
169 |
$ |
— |
|||||||||
Charge
associated with a modified
coinsurance arrangement |
$ |
(8 |
) |
$ |
— |
||||||||
Effect
of new accounting pronouncement
(see Note
2
to the Financial Statements) |
$ |
— |
$ |
(11 |
) |
· |
gain
recognition related to the sale of the retirement benefits
business; |
· |
results
of a modified coinsurance arrangement; |
· |
expenses
associated with the run-off of this business;
and |
· |
results
of the retirement benefits business prior to the April 2004
sale. |
· |
normal
deferred gain amortization of $14 million pre-tax for the three months of
2005; |
· |
accelerated
gain amortization of $260 million pre-tax for the three months of 2005 as
described on page 21; and |
· |
prior
to the sale of the retirement benefits business on April 1, 2004, other
revenues also reflected changes in fair value of securities supporting
experience-rated pension policyholder contracts. Under the
experience-rating process, gains and losses on assets related to these
contracts generally accrued to policyholders and were offset by amounts
included in benefits and expenses. |
FINANCIAL
SUMMARY
|
Three
Months
Ended
March
31, |
||||||
(In
millions) |
2005 |
|
2004 |
||||
Premiums
and fees |
$ |
23 |
$ |
21 |
|||
Net
investment income |
24 |
24 |
|||||
Other
revenues |
38 |
(30 |
) | ||||
Segment
revenues |
85 |
15 |
|||||
Benefits
and expenses |
110 |
24 |
|||||
Loss
before income taxes
(benefits) |
(25 |
) |
(9 |
) | |||
Income
taxes (benefits) |
(9 |
) |
1 |
||||
Segment
loss |
$ |
(16 |
) |
$ |
(10 |
) | |
Realized
investment gains,
net
of taxes |
$ |
1 |
$ |
1 |
FINANCIAL
SUMMARY |
Three
Months Ended
March
31, |
||||||
(In
millions) |
2005 |
|
2004 |
||||
Premiums
and fees |
$ |
30 |
$ |
34 |
|||
Net
investment income |
112 |
119 |
|||||
Other
revenues |
27 |
47 |
|||||
Segment
revenues |
169 |
200 |
|||||
Benefits
and expenses |
124 |
173 |
|||||
Income
before taxes |
45 |
27 |
|||||
Income
taxes |
15 |
9 |
|||||
Segment
earnings |
$ |
30 |
$ |
18 |
|||
Realized
investment gains
(losses),
net of taxes |
$ |
(1 |
) |
$ |
2 |
· |
deferred
gains recognized from the 1998 sale of the individual life insurance and
annuity business; |
· |
corporate
life insurance; |
· |
leveraged
corporate life insurance (corporate life insurance on which policy loans
are outstanding); |
· |
settlement
annuity business; and |
· |
certain
investment management services (a significant portion of which was sold
during the fourth quarter of 2004). |
· |
severance
and employee retention costs in 2004 associated with the investment
operations supporting the sold retirement benefits business;
and |
· |
higher
earnings in the leveraged corporate insurance business due to favorable
mortality experience. |
FINANCIAL
SUMMARY |
Three
Months Ended
March
31, |
||||||
(In
millions) |
2005 |
|
2004 |
||||
Segment
loss |
$ |
(35 |
) |
$ |
(48 |
) | |
Special
item (after-tax)
included
in segment loss: |
|||||||
Cost
reduction charge |
$ |
(19 |
) |
$ |
(20 |
) |
· |
maintaining
appropriate levels of liquidity in its investment
portfolio; |
· |
using
cash flows from operating activities; and |
· |
matching
investment maturities to the estimated duration of the related insurance
and contractholder liabilities. |
(In
millions) |
2005 |
|
2004 |
||||
Operating
activities |
$ |
271 |
$ |
1.123 |
|||
Investing
activities |
$ |
(54 |
) |
$ |
(515 |
) | |
Financing
activities |
$ |
(336 |
) |
$ |
(509 |
) |
· |
The
decrease in cash flows from operating activities primarily reflects 2004
net proceeds from sales and maturities of securities supporting
experience-rated pension policyholder contracts of $782 million. Such
proceeds, which ceased with the sale of the retirement benefits business,
were used to fund |
most of the 2004 withdrawals from contractholder deposit funds discussed below under financing. |
· |
Cash
used in investing activities primarily consisted of net purchases of
investments ($31 million) and net purchases of property and equipment ($23
million). |
· |
Cash
used in financing activities primarily consisted of dividends on and
repurchases of common stock of $245 million and change in cash
overdraft position of $193 million, partially offset by net deposits
to contractholder deposit funds of $8 million and proceeds from issuances
of common stock under CIGNA's stock plans of $94
million. |
· |
Cash
used in investing activities primarily consisted of net purchases of
investments ($493 million) and net purchases of property and equipment
($18 million). |
· |
Cash
used in financing activities consisted primarily of payments of dividends
on common stock ($47 million), and net withdrawals from contractholder
deposit funds ($431 million) and change in cash overdraft
position ($50 million). |
· |
provide
capital necessary to support growth and maintain or improve the financial
strength ratings of subsidiaries; and |
· |
return
capital to investors through share
repurchase. |
· |
provide
any funding to subsidiaries needed to support growth and maintain or
improve their financial strength ratings; |
· |
provide
for the capital requirements of its
subsidiaries; |
· |
meet
debt service requirements and pay dividends to CIGNA
shareholders; |
· |
satisfy
pension plan funding requirements; and |
· |
fund
CIGNA's program to reduce the equity market risks associated with
guaranteed minimum death benefit
contracts. |
· |
management
uses cash for investment opportunities; |
· |
a
substantial insurance or contractholder liability becomes due before
related investment assets mature; or |
· |
regulatory
restrictions prevent the insurance and HMO subsidiaries from distributing
cash to the parent company. |
CG
Life Insurance Ratings |
CIGNA
Corporation
Debt
Ratings | ||
Senior
Debt |
Commercial
Paper | ||
A.M.
Best |
A- |
— |
— |
Moody’s |
A3 |
Baa3 |
P3 |
S&P |
A- |
BBB |
A2 |
Fitch |
A |
BBB |
F2 |
· |
No
annuitants surrendered their accounts; and |
· |
All
annuitants lived to elect their benefits;
and |
· |
All
annuitants elected to receive their benefit on the first available date (
2005 through 2014); and |
· |
All
underlying mutual fund investment values remained at the March 31, 2005
value of $3.2 billion, with no future
returns. |
(In
millions) |
March
31,
2005 |
|
December
31,
2004 |
||||
Problem
bonds |
$ |
32 |
$ |
37 |
|||
Potential
problem bonds |
$ |
40 |
$ |
44 |
|||
Problem
mortgage loans |
$ |
17 |
$ |
65 |
|||
Potential
problem mortgage loans |
$ |
72 |
$ |
72 |
|||
Foreclosed
real estate |
$ |
10 |
$ |
10 |
· |
· |
minimum
pension liabilities since equity securities comprise a significant portion
of the assets of CIGNA’s employee pension plans.
|
1. |
increased
medical costs that are higher than anticipated in establishing premium
rates in CIGNA’s health care operations, including increased use and costs
of medical services; |
2. |
increased
medical, administrative, technology or other costs resulting from new
legislative and regulatory requirements imposed on CIGNA’s employee
benefits businesses (see Employee benefits regulation
on page 23 for more information); |
3. |
challenges
and risks associated with implementing the improvement initiatives in the
health care operations, the organizational realignment and the reduction
of overall CIGNA and health care cost structure, including that
operational efficiencies and medical cost benefits do not emerge as
expected and that membership does not stabilize and begin to grow,
resulting in significantly greater than expected reductions in medical
membership; |
4. |
risks
associated with the amount and timing of gain recognition on the sale of
CIGNA's retirement benefits business; |
5. |
risks
associated with pending and potential state and federal health care class
action lawsuits, purported securities class action lawsuits, disputes
regarding reinsurance arrangements, other litigation and regulatory
actions challenging CIGNA’s businesses and the outcome of pending
government proceedings; |
6. |
heightened
competition, particularly price competition, which could reduce product
margins and constrain growth in CIGNA’s businesses, primarily the health
care business; |
7. |
significant
changes in interest rates; |
8. |
downgrades
in the financial strength ratings of CIGNA’s insurance subsidiaries, which
could, among other things, adversely affect new sales and retention of
current business; |
9. |
limitations
on the ability of CIGNA's insurance subsidiaries to dividend capital to
the parent company as a result of downgrades in the subsidiaries’
financial strength ratings, changes in statutory reserve or capital
requirements or other financial
constraints; |
10. |
inability
of the program adopted by CIGNA to substantially reduce equity market
risks for reinsurance contracts that guarantee minimum death benefits
under certain variable annuities (including possible market difficulties
in entering into appropriate futures and forward contracts and in matching
such contracts to the underlying equity risk);
|
11. |
adjustments
to the reserve assumptions and other considerations (including lapse,
partial surrender, mortality, interest rates and volatility) used in
estimating CIGNA's liabilities for reinsurance contracts that guarantee
minimum death benefits under certain variable annuities;
|
12. |
adjustments
to the assumptions (including annuity election rates and reinsurance
recoverables) used in estimating CIGNA’s assets and liabilities for
reinsurance contracts that guarantee minimum income benefits under certain
variable annuities; |
13. |
significant
stock market declines, which could, among other things, result in
increased pension expenses in CIGNA’s pension plan in future periods and
the recognition of additional pension obligations;
|
14. |
unfavorable
claims experience related to workers’ compensation and personal accident
exposures of the run-off reinsurance business, including losses
attributable to the inability to recover claims from
retrocessionaires; |
15. |
significant
deterioration in economic conditions, which could have an adverse effect
on CIGNA’s operations and investments; |
16. |
changes
in federal income tax laws; |
17. |
potential
public health epidemics and bio-terrorist activity, which could, among
other things, cause our covered medical expenses and mortality
experience to rise significantly, depending on the severity of the
event and number of individuals affected who are covered under CIGNA’s
insurance products; and |
18. |
risk
factors detailed in CIGNA's Form 10-K for the fiscal year ended December
31, 2004, including the Cautionary Statement in Management's Discussion
and Analysis. |
Issuer Purchases of Equity Securities |
|||||||||||||
Period |
Total # of shares purchased(1) |
Average price paid per share |
Total # of shares purchased as part of publicly announced
program (2) |
Approximate dollar value of shares that may yet be purchased
as part of publicly announced program (3) |
|||||||||
January 1-31, 2005 |
591,105 |
$80.53 |
591,100 |
$333,668,658 |
|||||||||
February 1-28, 2005 |
721,877 |
$89.47 |
659,812 |
$774,530,233 |
|||||||||
March 1-31, 2005 |
1,539,557 |
$87.97 |
1,517,442 |
$641,119,008 |
|||||||||
Total |
2,852,539 |
$86.81 |
2,768,354 |
N/A |
(1) |
Includes shares tendered by employees as payment of taxes
withheld on the exercise of stock options and the vesting of restricted
stock granted under the Company’s equity compensation plans. Employees
tendered 5 shares in January, 62,065 shares in February, and 22,115 shares
in March. |
(2) |
CIGNA has had a repurchase program for many years, and has
had varying levels of repurchase authority and activity under this
program. The program has no expiration date. CIGNA suspends activity under
this program from time to time, generally without public announcement.
Remaining authorization under the program was approximately $641 million
as of March 31, 2005 and $568 million as of May 3,
2005. |
(3) |
Approximate dollar value of shares is as of the last date of
the applicable month. |
Number |
Description |
Method
of Filing |
10.1 |
Description
of Amendments to Executive Management Compensation
Arrangements |
Filed
herewith. |
10.2 |
CIGNA
Long-Term Incentive Plan, as amended and restated |
Filed
as Appendix B to the registrant’s definitive proxy statement filed March
21, 2005 and incorporated herein by reference. |
31.1 |
Certification
of Chief Executive Officer of CIGNA Corporation pursuant to Rule 13a-14(a)
or Rule 15d-14(a) of the Securities Exchange Act of 1934 |
Filed
herewith. |
31.2 |
Certification
of Chief Financial Officer of CIGNA Corporation pursuant to Rule 13a-14(a)
or Rule 15d-14(a) of the Securities Exchange Act of 1934 |
Filed
herewith. |
32.1 |
Certification
of Chief Executive Officer of CIGNA Corporation pursuant to Rule 13a-14(b)
or Rule 15d-14(b) and 18 U.S.C. Section 1350 |
Furnished
herewith. |
32.2 |
Certification
of Chief Financial Officer of CIGNA Corporation pursuant to Rule 13a-14(b)
or Rule 15d-14(b) and 18 U.S.C. Section 1350 |
Furnished
herewith. |